K-numberK241186
Device nameSynthetic Bone Graft Particulate
ApplicantShenzhen Dazhou Medical Technology Co., Ltd.
Product codeLYC
Device classClass II
Decision dateFeb 21, 2025
DecisionSubstantially Equivalent
Regulation872.3930
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Synthetic Bone Graft Particulate is a synthetic absorbable bone graft substitute made from 45S5 bioactive glass in particulate form (0.5–1 mm particles). It is mixed with sterile saline to form a paste and packed into tooth extraction sockets to augment alveolar bone; the material is progressively resorbed and replaced by new bone tissue during healing.

Technological characteristics

Both the proposed device and predicate (PerioGlas) are calcium phospho-silicate bioactive glass materials in irregular dense particulate morphology designed as non-structural scaffolds. The proposed device has a particle size of 500–1000 microns compared to the predicate's 90–710 microns, but both exhibit similar bioactivity, resorption kinetics (majority absorbed by six months), and osteoconductive bone infiltration mechanisms.

Test standards cited

ISO 11137 (sterilization), ISO 10993 series (biocompatibility: cytotoxicity, sensitization, irritation, implantation, genotoxicity), USP <151> and ISO 10993-11 (pyrogenicity), ASTM F1538-03 (chemical composition and crystallinity), ISO 9276-6 (morphology), USP <786> (particle size distribution), USP <791> (pH), ISO 23317 (bioactivity), OECD Test No. 105 (water solubility), and USP <85> (bacterial endotoxin).

Substantial equivalence argument

Both devices share identical material composition (bioactive glass), same intended use (alveolar bone augmentation in extraction sockets), and equivalent application method (gentle packing as non-structural scaffold). Although the proposed device's particle size range (500–1000 µm) is slightly narrower than the predicate's (90–710 µm), both fall within overlapping ranges and demonstrate comparable bioactivity and resorption profiles. A canine dental defect model study comparing the proposed and predicate devices showed equivalent in vivo absorbability and bone healing/regeneration at 4, 12, and 26 weeks post-operation.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →